Mostrando 3 resultados de: 3
Filtros aplicados
CYP2D6 gene polymorphisms and pbkp_redicted phenotypes in eight indigenous groups from northwestern Mexico
ArticleAbstract: Aim: Polymorphisms in CYP2D6 impact the interindividual and interethnic variability of drug efficienPalabras claves:allele frequency, CYP2D6polymorphism, Mexican indigenous, pbkp_redicted phenotype, pharmacogeneticsAutores:Adrián LLerena, Galaviz-Hernandez C., Garza-Veloz I., Lazalde-Ramos B.P., Martínez-Fierro M.L., Naranjo M.E.G., Sosa-Macías M.G.Fuentes:scopusPharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America
Conference ObjectAbstract: Congress of Pharmacogenetics and Personalized Medicine. Ethnicity, clinical implementation and regulPalabras claves:clinical trials, Latin American populations, metabolic genotypes, Metabolic phenotypes, native populations, pharmacogenetics, pharmacovigilanceAutores:Adrián LLerena, Altamirano C., Céspedes-Garro C., Enrique Terán, Francisco J.López Hernández, Galaviz-Hernandez C., Humberto Fariñas, Jung-Cook H., López-López M., MARTHA FORS, Martha M. Fors-López, Moya G.E., Ramirez R., Remírez D., Sosa-Macías M.G., Tarazona-Santos E.M., William F. WatersFuentes:googlescopusPopulation pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)
Conference ObjectAbstract: MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the IPalabras claves:Cytochrome p450, drug metabolism, genome-wide analyses, Ibero-Americans populations, Metabolic phenotypes, next-generation sequencing, pharmacogenetics, Population geneticsAutores:Acosta H., Adrián LLerena, Céspedes-Garro C., Enrique Terán, Galaviz-Hernandez C., Moya G.E., Penãs-Lledó E.M., Ramirez R., Sosa-Macías M.G., Tarazona-Santos E.M.Fuentes:googlescopus